Evidence map›Paper›PMID 41551372›Full record

ArticleJournal of biomedical optics2026

Phasor-based FLIM analysis of NAD(P)H and FAD autofluorescence for label-free bacterial classification.

Piet Dyrøy, Julius Heitz, Hauke Studier, Sonja Johannsmeier, Tammo Ripken

Abstract read
In one paragraph

Article in Journal of biomedical optics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Piet DyrøyLeibniz Universität Hannover, Institute of Quantum Optics, Hannover, Germany.ORCID https://orcid.org/0009-0007-3476-178X
Julius HeitzBecker & Hickl GmbH, Berlin, Germany.
Hauke StudierBecker & Hickl GmbH, Berlin, Germany.
Sonja JohannsmeierLaser Zentrum Hannover e.V, Life Sciences Department, Hannover, Germany.ORCID https://orcid.org/0000-0002-8618-9187
Tammo RipkenLaser Zentrum Hannover e.V, Life Sciences Department, Hannover, Germany.ORCID https://orcid.org/0000-0003-3512-9544

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Significance: Bacterial contamination poses significant risks, particularly in medical settings, where timely identification is crucial for effective treatment. Traditional diagnostic methods often fail to provide rapid results, underlining the need for alternative approaches. Aim: We investigate the potential of fluorescence lifetime imaging microscopy (FLIM) for fast label-free classification of bacterial species based on their growth states and intrinsic fluorescence characteristics. Approach: Utilizing two-photon excitation microscopy, we examined the fluorescence lifetimes of the endogenous fluorophores NAD(P)H and FAD in Results: Results revealed distinct fluorescence lifetime profiles for each species, with clear differences observed in the exponential growth phase. Notably, Conclusion: These findings demonstrate that FLIM-based metabolic imaging can distinguish between bacterial species without labels, providing a promising basis for rapid, high-resolution diagnostic tools in clinical and research settings. We underscore the potential of FLIM as a powerful tool for bacterial classification, offering advantages in speed and spatial resolution over traditional methods.

Indexed as

BacteriaFlavin-Adenine DinucleotideImage Processing, Computer-AssistedMicroscopy, Fluorescence, MultiphotonNADPEscherichia coli K12Microscopy, FluorescencePseudomonas fluorescensStaphylococcus aureusFlavin-Adenine DinucleotideNADPbacterial classificationFADfluorescence lifetime imaging microscopylabel-free imagingmetabolic imagingNAD(P)H

Identifiers

PMID41551372
PMCPMC12811912

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.